Abstract
The rapid development of protein-based pharmaceuticals highlights the need for robust analytical methods to ensure their quality and stability. Among proteins used in pharmaceutical applications, an important and ever increasing role is represented by monoclonal antibodies and large proteins, which are often modified to enhance their activity or stability when used as drugs. The bioactivity and the stability of those proteins are closely related to the maintenance of their complex structure, which however are influenced by many external factors that can cause degradation and/or aggregation. The presence of aggregates in these drugs could reduce their bioactivity and bioavailability, and induce immunogenicity. The choice of the proper analytical method for the analysis of aggregates is fundamental to understand their (size) dimensional range, their amount, and if they are present in the sample as generated by an aggregation or as an artifact due to the method itself. Size exclusion chromatography is one of the most important techniques for the quality control of pharmaceutical proteins; however, its application is limited to relatively low molar mass aggregates. Among the techniques for the size characterization of proteins, field-flow fractionation (FFF) represents a competitive choice because of its soft mechanism due to the absence of a stationary phase and application in a broader size range, from nanometer- to micrometer-sized analytes. In this paper, the microcolumn variant of FFF, the hollow-fiber flow FFF, was online coupled with multi-angle light scattering, and a method for the characterization of aggregates with high reproducibility and low limit of detection was demonstrated employing an avidin derivate as sample model.
HF5-UV-MALS of therapeutic proteins: aggregation study
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Birch JR, Onakunle Y (2005) Meth Mol Biol 308:1–16
Walsh G (2010) Nat Biotechnol 28:917–924
Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS (2010) Pharm Res 27(4):544–575
Wang W, Nema S, Teagarden D (2010) Int J Pharm 390(2):89–99
Carpenter J, Cherney B, Lubinecki A, Ma S, Marszal E, Mire-Sluis A, Nikolai T, Novak J, Ragheb J, Simak J (2010) Biologicals 38:602–611
Mahler H-C, Friess W, Grauschopf U, Kiese S (2009) J Pharm Sci 98(9):2909–2934
Hilario E, Jacobson F (2006) AAPS J 8(3):E572–E579
Zolls S, Tantipolphan R, Wiggenhorn M, Winter G, Jiskoot W, Friess W, Hawe A (2012) J Pharm Sci 101(3):914–935
Philo JS (2009) Curr Pharm Biotechnol 10:358–372
Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G (2010) J Pharm Sci 99(5):2200–2208
Qureshi RN, Kok WT (2011) Anal Bioanal Chem 399:1401–1411
Pollastrini J, Narhi LO, Jiang Y, Cao S (2012) In: Williams KSR, Caldwell KD (eds) Field-flow fractionation in biopolymers analysis. Springer, New York
Williams SKR, Caldwell KD (2012) Field-flow fractionation in Biopolymers Analysis. Springer, New York
Reschiglian P, Zattoni A, Roda B, Michelini E, Roda A (2005) Trends Biotechnol 23:475–183, and references therein
Roda B, Zattoni A, Reschiglian P, Moon MH, Mirasoli M, Michelini E, Roda A (2009) Anal Chim Acta 635:132–143
Schachermeyer S, Zhong W (2012) In: Williams KSR, Caldwell KD (eds) Field-flow fractionation in biopolymers analysis. Springer, New York
den Engelsman J, Garidel P, Smulders R, Koll H, Smith B, Bassarab S, Seidl A, Hainzl O, Jiskoot W (2011) Pharm Res 28:920–933
Cao S, Pollastrini J, Jiang Y (2009) Curr Pharm Biotechnol 10(4):382–390
Zattoni A, Casolari S, Rambaldi DC, Reschiglian P (2007) Curr Anal Chem 3(4):310–323
Reschiglian P, Zattoni A, Cinque L, Roda B, Dal Piaz F, Roda A, Moon MH, Min BR (2004) Anal Chem 76:2103–2111
Reschiglian P, Zattoni A, Roda B, Cinque L, Parisi D, Roda A, Moon MH, Min BR, Dal Piaz F (2005) Anal Chem 77:47–56
Roda A, Parisi D, Guardigli M, Zattoni A, Reschiglian P (2006) Anal Chem 78:1085–1092
Zattoni A, Rambaldi DC, Roda B, Parisi D, Roda A, Moon MH, Reschiglian P (2008) J Chromatogr A 1183:135–142
Johann C, Elsenberg S, Roesch U, Rambaldi DC, Zattoni A, Reschiglian P (2011) J Chromatogr A 1218:4126–4131
De Santis R, Leoni B, Rosi A, Albertoni C, Forni G, Cojoca R, Iezzi M, Musiani P, Paganelli G, Chinol M, Carminati P (2010) Cancer Biother Radiopharm 25(2):143–148
Verdoliva A, Bellofiore P, Rivieccio V, Catello S, Colombo M, Albertoni C, Rosi A, Leoni B, Anastasi AM, De Santis R (2010) J Biol Chem 285:9090–9099
Hamada H, Arakwa T, Shiraki K (2009) Curr Pharm Biotechnol 10:400–407
Kawahara K, Tanford C (1966) J Biol Chem 241(13):3228–3232
Conflict of interest
Andrea Zattoni, Barbara Roda, and Pierluigi Reschiglian are associates of the academic spinoff company byFlow Srl (Bologna, Italy). The company mission includes know-how transfer, development, and application of novel technologies and methodologies for the analysis and characterization of samples of nano-biotechnological interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in the topical collection Field-Flow Fractionation with guest editors S. Kim R. Williams and Karin D. Caldwell.
Rights and permissions
About this article
Cite this article
Reschiglian, P., Roda, B., Zattoni, A. et al. Hollow-fiber flow field-flow fractionation with multi-angle laser scattering detection for aggregation studies of therapeutic proteins. Anal Bioanal Chem 406, 1619–1627 (2014). https://doi.org/10.1007/s00216-013-7462-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-013-7462-4